Related references
Note: Only part of the references are listed.Dipeptidyl-peptidase IV inhibition improves pathophysiology of heart failure and increases survival rate in pressure-overloaded mice
Ayako Takahashi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
DPP-4 Inhibition Attenuates Cardiac Dysfunction and Adverse Remodeling Following Myocardial Infarction in Rats with Experimental Diabetes
Kim Alexander Connelly et al.
CARDIOVASCULAR THERAPEUTICS (2013)
Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease
Jianhua He et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2013)
Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction
Per-Henrik Groop et al.
DIABETES CARE (2013)
Origin and function of myofibroblasts in kidney fibrosis
Valerie S. LeBleu et al.
NATURE MEDICINE (2013)
Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
Keizo Kanasaki et al.
Frontiers in Endocrinology (2013)
Pathophysiology of the aging kidney and therapeutic interventions
Keizo Kanasaki et al.
HYPERTENSION RESEARCH (2012)
Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis
Hal E. Broxmeyer et al.
NATURE MEDICINE (2012)
Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced Obesity
Matthias Kern et al.
PLOS ONE (2012)
Diabetic angiopathy and angiogenic defects
Ling Xu et al.
FIBROGENESIS & TISSUE REPAIR (2012)
Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats
Wei Jing Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
miR-29 Is a Major Regulator of Genes Associated with Pulmonary Fibrosis
Leah Cushing et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Therapy in the Early Stage: Incretins
Simona Cernea et al.
DIABETES CARE (2011)
Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
Chinmay S. Marathe et al.
EXPERIMENTAL DIABETES RESEARCH (2011)
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
Armanda Casrouge et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Effects of DPP-4 inhibition on cardiac metabolism and function in mice
M. Lenski et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Effects of DPP-4 Inhibitors on the Heart in a Rat Model of Uremic Cardiomyopathy
Lyubov Chaykovska et al.
PLOS ONE (2011)
DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes
Nga N. Ta et al.
ATHEROSCLEROSIS (2010)
Pharmacokinetics of dipeptidylpeptidase-4 inhibitors
A. J. Scheen
DIABETES OBESITY & METABOLISM (2010)
The Metabolism and Disposition of the Oral Dipeptidyl Peptidase-4 Inhibitor, Linagliptin, in Humans
Stefan Blech et al.
DRUG METABOLISM AND DISPOSITION (2010)
High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells
Bin Du et al.
FEBS LETTERS (2010)
Renal Medullary MicroRNAs in Dahl Salt-Sensitive Rats miR-29b Regulates Several Collagens and Related Genes
Yong Liu et al.
HYPERTENSION (2010)
Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation
W. T. Arscott et al.
ONCOGENE (2009)
The role of endothelial-to-mesenchymal transition in cancer progression
S. Potenta et al.
BRITISH JOURNAL OF CANCER (2008)
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
Eva van Rooij et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Elisabeth M. Zeisberg et al.
NATURE MEDICINE (2007)
Increase in DPP-IV in the intestine, liver and kidney of the rat treated with high fat diet and streptozotocin
Jian Yang et al.
LIFE SCIENCES (2007)
Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors
Hikaru Sugimoto et al.
DIABETES (2007)
Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation
Guido Boerrigter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex
G Ghersi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
